Phase 3CompletedAge-related condition
Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
24-Week Study to Evaluate the Efficacy/Safety of Transdermal Testosterone in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen Therapy.
- Sponsor
- Warner Chilcott (Industry)
- Enrollment
- 272 enrolled
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Testosterone; Placebo
- Ages
- adults, older adults
- Registry
- NCT00384046
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to examine whether the transdermal testosterone system (TTS) is effective and safe in the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women who are on transdermal estrogen.
Primary outcomes
- To assess the efficacy of the TTS by measuring change in frequency of total satisfying episodes. The safety assessment of TTS with various parameters.
History
Last registry update
Primary completion
Started
Registered